DAVITA Business Summary

DaVita Inc. operates as a premier provider of kidney care services, generating the vast majority of its revenue through the delivery of outpatient hemodialysis and peritoneal dialysis treatments. The company’s operations are segmented into U.S. Dialysis, which provides center-based and home-based services; Integrated Kidney Care (IKC), which utilizes value-based care models to manage the total cost of patient health; and DaVita International. By early 2026, the firm has solidified its shift toward a "Village" culture that emphasizes clinical innovation and the expansion of its home dialysis footprint, which now represents a significant portion of its treatment volume. Within the market, DaVita occupies a dominant duopoly position alongside Fresenius Medical Care, while also competing with smaller regional and national providers such as U.S. Renal Care and Satellite Healthcare. The company, which rose to prominence as Total Renal Care before being rebranded by former CEO Kent Thiry, is currently led by CEO Javier J. Rodriguez, a veteran executive who has been with the firm since 1998. The leadership suite includes CFO Joel Ackerman, COO David Maughan, and Chief Medical Officer Dr. Jeff Giullian. In late 2025, the company further strengthened its executive ranks by appointing Stephanie Hendrickson as Chief People Officer and Steve Phillips as Chief Strategy Officer to lead its "Care Transformation" and venture initiatives. DaVita’s board is chaired by Pamela M. Arway. A cornerstone of the company’s institutional support is Berkshire Hathaway, which holds a massive ~45% stake, signaling long-term confidence in DaVita’s cash flow and its dominant position in the dialysis market.